These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29449156)

  • 21. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
    Dörr T; Vulić M; Lewis K
    PLoS Biol; 2010 Feb; 8(2):e1000317. PubMed ID: 20186264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escherichia coli persister cells suppress translation by selectively disassembling and degrading their ribosomes.
    Cho J; Rogers J; Kearns M; Leslie M; Hartson SD; Wilson KS
    Mol Microbiol; 2015 Jan; 95(2):352-64. PubMed ID: 25425348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
    Aedo SJ; Orman MA; Brynildsen MP
    BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Ma C; Sim S; Shi W; Du L; Xing D; Zhang Y
    FEMS Microbiol Lett; 2010 Feb; 303(1):33-40. PubMed ID: 20041955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persister cells.
    Lewis K
    Annu Rev Microbiol; 2010; 64():357-72. PubMed ID: 20528688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.
    Keren I; Shah D; Spoering A; Kaldalu N; Lewis K
    J Bacteriol; 2004 Dec; 186(24):8172-80. PubMed ID: 15576765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polynucleotide Phosphorylase Mediates a New Mechanism of Persister Formation in Escherichia coli.
    Wu N; Zhang Y; Zhang S; Yuan Y; Liu S; Xu T; Cui P; Zhang W; Zhang Y
    Microbiol Spectr; 2023 Feb; 11(1):e0154622. PubMed ID: 36475972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ldhA gene encoding the fermentative lactate dehydrogenase of Escherichia coli.
    Bunch PK; Mat-Jan F; Lee N; Clark DP
    Microbiology (Reading); 1997 Jan; 143 ( Pt 1)():187-195. PubMed ID: 9025293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A General Method for Measuring Persister Levels in Escherichia coli Cultures.
    Kaldalu N; Jõers A; Ingelman H; Tenson T
    Methods Mol Biol; 2016; 1333():29-42. PubMed ID: 26468097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine tuning the transcription of ldhA for D-lactate production.
    Zhou L; Shen W; Niu DD; Tian KM; Prior BA; Shi GY; Singh S; Wang ZX
    J Ind Microbiol Biotechnol; 2012 Aug; 39(8):1209-17. PubMed ID: 22430499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli.
    Kim Y; Wood TK
    Biochem Biophys Res Commun; 2010 Jan; 391(1):209-13. PubMed ID: 19909729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
    Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
    Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular model for persister in E. coli.
    Lou C; Li Z; Ouyang Q
    J Theor Biol; 2008 Nov; 255(2):205-9. PubMed ID: 18721814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Tryptophan represses persister formation via inhibiting bacterial motility and promoting antibiotics absorption.
    Li Y; Liu B; Guo J; Cong H; He S; Zhou H; Zhu F; Wang Q; Zhang L
    Future Microbiol; 2019 Jun; 14():757-771. PubMed ID: 31271063
    [No Abstract]   [Full Text] [Related]  

  • 36. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
    Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
    FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
    Morgan J; Smith M; Mc Auley MT; Enrique Salcedo-Sora J
    Microbiology (Reading); 2018 Nov; 164(11):1432-1445. PubMed ID: 30247120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Historical Perspective on Bacterial Persistence.
    Verstraeten N; Knapen W; Fauvart M; Michiels J
    Methods Mol Biol; 2016; 1333():3-13. PubMed ID: 26468095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
    Jiang W; Zhou F; Li N; Li Q; Wang L
    Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impacts of global transcriptional regulators on persister metabolism.
    Mok WW; Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2015 May; 59(5):2713-9. PubMed ID: 25712354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.